|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended September 30, 2018
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
32-0436529
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
x
|
Non-accelerated filer
|
|
¨
|
|
Smaller reporting company
|
|
¨
|
|
|
|
|
Emerging growth company
|
|
¨
|
|
|
Item
|
Page
|
|
|
|
|
|
|
5) Other Information
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
|
|
|
|
|
||||
|
|
(in thousands of dollars,
except unit amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
17,041
|
|
|
$
|
27,008
|
|
Receivable under the Investment Management Agreement—Westlake Chemical
Corporation ("Westlake")
|
|
151,875
|
|
|
136,510
|
|
||
Accounts receivable, net—Westlake
|
|
65,628
|
|
|
43,884
|
|
||
Accounts receivable, net—third parties
|
|
22,544
|
|
|
18,083
|
|
||
Inventories
|
|
5,004
|
|
|
5,590
|
|
||
Prepaid expenses and other current assets
|
|
491
|
|
|
314
|
|
||
Total current assets
|
|
262,583
|
|
|
231,389
|
|
||
Property, plant and equipment, net
|
|
1,161,203
|
|
|
1,196,245
|
|
||
Goodwill
|
|
5,814
|
|
|
5,814
|
|
||
Deferred charges and other assets, net
|
|
65,403
|
|
|
81,828
|
|
||
Total assets
|
|
$
|
1,495,003
|
|
|
$
|
1,515,276
|
|
LIABILITIES
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts payable—Westlake
|
|
$
|
41,274
|
|
|
$
|
14,027
|
|
Accounts payable—third parties
|
|
6,402
|
|
|
10,516
|
|
||
Accrued liabilities
|
|
18,911
|
|
|
15,697
|
|
||
Total current liabilities
|
|
66,587
|
|
|
40,240
|
|
||
Long-term debt payable to Westlake
|
|
477,608
|
|
|
473,960
|
|
||
Deferred income taxes
|
|
1,626
|
|
|
2,220
|
|
||
Other liabilities
|
|
53
|
|
|
107
|
|
||
Total liabilities
|
|
545,874
|
|
|
516,527
|
|
||
Commitments and contingencies (Note 12)
|
|
|
|
|
|
|
||
EQUITY
|
|
|
|
|
||||
Common unitholders—public (18,125,141 and 18,112,500 units issued and outstanding at
September 30, 2018 and December 31, 2017, respectively) |
|
410,555
|
|
|
411,228
|
|
||
Common unitholder—Westlake (14,122,230 and 14,122,230 units issued and outstanding at
September 30, 2018 and December 31, 2017, respectively) |
|
49,511
|
|
|
50,265
|
|
||
General partner—Westlake
|
|
(242,573
|
)
|
|
(241,958
|
)
|
||
Accumulated other comprehensive income
|
|
—
|
|
|
279
|
|
||
Total Westlake Chemical Partners LP partners' capital
|
|
217,493
|
|
|
219,814
|
|
||
Noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")
|
|
731,636
|
|
|
778,935
|
|
||
Total equity
|
|
949,129
|
|
|
998,749
|
|
||
Total liabilities and equity
|
|
$
|
1,495,003
|
|
|
$
|
1,515,276
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(in thousands of dollars, except unit amounts and per unit data)
|
||||||||||||||
Revenue
|
|
|
|
|
|
|
|
|
||||||||
Net sales—Westlake
|
|
$
|
313,381
|
|
|
$
|
258,049
|
|
|
$
|
802,085
|
|
|
$
|
711,968
|
|
Net co-product, ethylene and other sales—third
parties
|
|
50,269
|
|
|
38,726
|
|
|
147,812
|
|
|
152,368
|
|
||||
Total net sales
|
|
363,650
|
|
|
296,775
|
|
|
949,897
|
|
|
864,336
|
|
||||
Cost of sales
|
|
269,743
|
|
|
201,372
|
|
|
666,367
|
|
|
571,401
|
|
||||
Gross profit
|
|
93,907
|
|
|
95,403
|
|
|
283,530
|
|
|
292,935
|
|
||||
Selling, general and administrative expenses
|
|
5,909
|
|
|
6,805
|
|
|
20,417
|
|
|
21,519
|
|
||||
Income from operations
|
|
87,998
|
|
|
88,598
|
|
|
263,113
|
|
|
271,416
|
|
||||
Other income (expense)
|
|
|
|
|
|
|
|
|
||||||||
Interest expense—Westlake
|
|
(5,639
|
)
|
|
(6,190
|
)
|
|
(16,052
|
)
|
|
(17,592
|
)
|
||||
Other income, net
|
|
668
|
|
|
162
|
|
|
1,742
|
|
|
1,844
|
|
||||
Income before income taxes
|
|
83,027
|
|
|
82,570
|
|
|
248,803
|
|
|
255,668
|
|
||||
Income tax provision (benefit)
|
|
(772
|
)
|
|
325
|
|
|
(186
|
)
|
|
925
|
|
||||
Net income
|
|
83,799
|
|
|
82,245
|
|
|
248,989
|
|
|
254,743
|
|
||||
Less: Net income attributable to noncontrolling
interest in OpCo
|
|
71,387
|
|
|
68,860
|
|
|
211,525
|
|
|
221,619
|
|
||||
Net income attributable to Westlake Chemical
Partners LP
|
|
$
|
12,412
|
|
|
$
|
13,385
|
|
|
$
|
37,464
|
|
|
$
|
33,124
|
|
Net income per limited partner unit attributable to
Westlake Chemical Partners LP (basic
and diluted)
|
|
|
|
|
|
|
|
|
||||||||
Common units
|
|
$
|
0.38
|
|
|
$
|
0.47
|
|
|
$
|
1.14
|
|
|
$
|
1.23
|
|
Subordinated units
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1.07
|
|
Weighted average limited partner units outstanding
(basic and diluted)
|
|
|
|
|
|
|
|
|
||||||||
Common units—public
|
|
18,119,980
|
|
|
13,050,000
|
|
|
18,116,433
|
|
|
12,975,412
|
|
||||
Common units—Westlake
|
|
14,122,230
|
|
|
14,122,230
|
|
|
14,122,230
|
|
|
5,711,289
|
|
||||
Subordinated units—Westlake
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,410,941
|
|
|
|
Partnership
|
|
|
|
|
||||||||||||||||||||||
|
|
Common Unitholders
—
Public
|
|
Common Unitholder
—
Westlake
|
|
Subordinated Unitholder
—
Westlake
|
|
General
Partner
—
Westlake
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Noncontrolling
Interests
in OpCo
|
|
Total
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
(in thousands of dollars)
|
|||||||||||||||||||||||||||
Balances at December 31, 2016
|
|
$
|
297,367
|
|
|
$
|
4,813
|
|
|
$
|
42,534
|
|
|
$
|
(242,430
|
)
|
|
$
|
200
|
|
|
$
|
818,479
|
|
|
$
|
920,963
|
|
Net income
|
|
15,355
|
|
|
3,389
|
|
|
13,328
|
|
|
1,052
|
|
|
—
|
|
|
221,619
|
|
|
254,743
|
|
|||||||
Net effect of cash flow hedge
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
26
|
|
|
—
|
|
|
26
|
|
|||||||
Proceeds from secondary public offering, net of finance
and other offering costs
|
|
110,739
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
110,739
|
|
|||||||
Subordinated unit conversion
|
|
—
|
|
|
42,352
|
|
|
(42,352
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Quarterly distributions to unitholders
|
|
(13,777
|
)
|
|
(1,529
|
)
|
|
(13,510
|
)
|
|
(696
|
)
|
|
—
|
|
|
—
|
|
|
(29,512
|
)
|
|||||||
Quarterly distribution to noncontrolling interest retained in
OpCo by Westlake
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(263,480
|
)
|
|
(263,480
|
)
|
|||||||
Balances at September 30, 2017
|
|
$
|
409,684
|
|
|
$
|
49,025
|
|
|
$
|
—
|
|
|
$
|
(242,074
|
)
|
|
$
|
226
|
|
|
$
|
776,618
|
|
|
$
|
993,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Balances at December 31, 2017
|
|
$
|
411,228
|
|
|
$
|
50,265
|
|
|
$
|
—
|
|
|
$
|
(241,958
|
)
|
|
$
|
279
|
|
|
$
|
778,935
|
|
|
$
|
998,749
|
|
Net income
|
|
20,641
|
|
|
16,090
|
|
|
—
|
|
|
733
|
|
|
—
|
|
|
211,525
|
|
|
248,989
|
|
|||||||
Net effect of cash flow hedge
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(279
|
)
|
|
—
|
|
|
(279
|
)
|
|||||||
Units issued for vested phantom units
|
|
292
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
292
|
|
|||||||
Quarterly distributions to unitholders
|
|
(21,606
|
)
|
|
(16,844
|
)
|
|
—
|
|
|
(1,348
|
)
|
|
—
|
|
|
—
|
|
|
(39,798
|
)
|
|||||||
Quarterly distribution to noncontrolling interest retained in
OpCo by Westlake
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(258,824
|
)
|
|
(258,824
|
)
|
|||||||
Balances at September 30, 2018
|
|
$
|
410,555
|
|
|
$
|
49,511
|
|
|
$
|
—
|
|
|
$
|
(242,573
|
)
|
|
$
|
—
|
|
|
$
|
731,636
|
|
|
$
|
949,129
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2018
|
|
2017
|
||||
|
|
|
|
|
||||
|
|
(in thousands of dollars)
|
||||||
Cash flows from operating activities
|
|
|
|
|
||||
Net income
|
|
$
|
248,989
|
|
|
$
|
254,743
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
||||
Depreciation and amortization
|
|
82,176
|
|
|
86,502
|
|
||
Loss from disposition of property, plant and equipment
|
|
593
|
|
|
2,627
|
|
||
Other gains, net
|
|
(96
|
)
|
|
(1,334
|
)
|
||
Changes in operating assets and liabilities
|
|
|
|
|
||||
Accounts receivable—third parties
|
|
(4,959
|
)
|
|
(4,541
|
)
|
||
Net accounts receivable—Westlake
|
|
5,088
|
|
|
68,556
|
|
||
Inventories
|
|
586
|
|
|
53
|
|
||
Prepaid expenses and other current assets
|
|
(177
|
)
|
|
(144
|
)
|
||
Accounts payable
|
|
(4,267
|
)
|
|
1,026
|
|
||
Accrued and other liabilities
|
|
2,279
|
|
|
5,018
|
|
||
Other, net
|
|
(208
|
)
|
|
(10,590
|
)
|
||
Net cash provided by operating activities
|
|
330,004
|
|
|
401,916
|
|
||
Cash flows from investing activities
|
|
|
|
|
||||
Additions to property, plant and equipment
|
|
(30,047
|
)
|
|
(56,607
|
)
|
||
Maturities of investments with Westlake under the Investment Management Agreement
|
|
270,050
|
|
|
—
|
|
||
Investments with Westlake under the Investment Management Agreement
|
|
(285,000
|
)
|
|
(119,000
|
)
|
||
Other
|
|
—
|
|
|
1,801
|
|
||
Net cash used for investing activities
|
|
(44,997
|
)
|
|
(173,806
|
)
|
||
Cash flows from financing activities
|
|
|
|
|
||||
Net proceeds from equity offering
|
|
—
|
|
|
110,739
|
|
||
Proceeds from debt payable to Westlake
|
|
3,648
|
|
|
155,257
|
|
||
Repayment of debt payable to Westlake
|
|
—
|
|
|
(272,765
|
)
|
||
Quarterly distributions to noncontrolling interest retained in OpCo by Westlake
|
|
(258,824
|
)
|
|
(263,480
|
)
|
||
Quarterly distributions to unitholders
|
|
(39,798
|
)
|
|
(29,512
|
)
|
||
Net cash used for financing activities
|
|
(294,974
|
)
|
|
(299,761
|
)
|
||
Net decrease in cash and cash equivalents
|
|
(9,967
|
)
|
|
(71,651
|
)
|
||
Cash and cash equivalents at beginning of period
|
|
27,008
|
|
|
88,900
|
|
||
Cash and cash equivalents at end of period
|
|
$
|
17,041
|
|
|
$
|
17,249
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
Trade customers
|
|
$
|
23,676
|
|
|
$
|
18,794
|
|
Allowance for doubtful accounts
|
|
(1,209
|
)
|
|
(711
|
)
|
||
|
|
22,467
|
|
|
18,083
|
|
||
Other
|
|
77
|
|
|
—
|
|
||
Accounts receivable, net—third parties
|
|
$
|
22,544
|
|
|
$
|
18,083
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
Finished products
|
|
$
|
4,596
|
|
|
$
|
5,244
|
|
Feedstock, additives and chemicals
|
|
408
|
|
|
346
|
|
||
Inventories
|
|
$
|
5,004
|
|
|
$
|
5,590
|
|
|
|
|
|
Marginal Percentage Interest in Distributions
|
||||
Total Quarterly Distribution Per Unit
|
|
Unitholders
|
|
IDR Holders
|
||
Above $1.2938 up to $1.4063
|
|
85.0
|
%
|
|
15.0
|
%
|
Above $1.4063 up to $1.6875
|
|
75.0
|
%
|
|
25.0
|
%
|
Above $1.6875
|
|
50.0
|
%
|
|
50.0
|
%
|
|
|
Marginal Percentage Interest in Distributions
|
||||
Total Quarterly Distribution Per Unit
|
|
Unitholders
|
|
IDR Holders
|
||
Above $0.3163 up to $0.3438
|
|
85.0
|
%
|
|
15.0
|
%
|
Above $0.3438 up to $0.4125
|
|
75.0
|
%
|
|
25.0
|
%
|
Above $0.4125
|
|
50.0
|
%
|
|
50.0
|
%
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Net income attributable to the Partnership
|
|
$
|
12,412
|
|
|
$
|
13,385
|
|
|
$
|
37,464
|
|
|
$
|
33,124
|
|
Less:
|
|
|
|
|
|
|
|
|
||||||||
Limited partners' distributions declared on common
units
|
|
13,566
|
|
|
12,107
|
|
|
39,559
|
|
|
22,454
|
|
||||
Limited partners' distributions declared on
subordinated units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,133
|
|
||||
Distributions declared with respect to the incentive
distribution rights
|
|
—
|
|
|
498
|
|
|
733
|
|
|
1,052
|
|
||||
Net income in excess of distribution (Distribution in excess of net income)
|
|
$
|
(1,154
|
)
|
|
$
|
780
|
|
|
$
|
(2,828
|
)
|
|
$
|
485
|
|
|
|
Three Months Ended September 30, 2018
|
||||||||||
|
|
Limited Partners' Common Units
|
|
Incentive Distribution Rights
|
|
Total
|
||||||
Net income attributable to the Partnership:
|
|
|
|
|
|
|
||||||
Distribution declared
|
|
$
|
13,566
|
|
|
$
|
—
|
|
|
$
|
13,566
|
|
Distribution in excess of net income
|
|
(1,154
|
)
|
|
—
|
|
|
(1,154
|
)
|
|||
Net income
|
|
$
|
12,412
|
|
|
$
|
—
|
|
|
$
|
12,412
|
|
Weighted average units outstanding:
|
|
|
|
|
|
|
||||||
Basic and diluted
|
|
32,242,210
|
|
|
|
|
32,242,210
|
|
||||
Net income per limited partner unit:
|
|
|
|
|
|
|
||||||
Basic and diluted
|
|
$
|
0.38
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2017
|
||||||||||
|
|
Limited Partners' Common Units
|
|
Incentive Distribution Rights
|
|
Total
|
||||||
Net income attributable to the Partnership:
|
|
|
|
|
|
|
||||||
Distribution declared
|
|
$
|
12,107
|
|
|
$
|
498
|
|
|
$
|
12,605
|
|
Net income in excess of distribution
|
|
780
|
|
|
—
|
|
|
780
|
|
|||
Net income
|
|
$
|
12,887
|
|
|
$
|
498
|
|
|
$
|
13,385
|
|
Weighted average units outstanding:
|
|
|
|
|
|
|
||||||
Basic and diluted
|
|
27,172,230
|
|
|
|
|
27,172,230
|
|
||||
Net income per limited partner unit:
|
|
|
|
|
|
|
||||||
Basic and diluted
|
|
$
|
0.47
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2018
|
||||||||||
|
|
Limited Partners' Common Units
|
|
Incentive Distribution Rights
|
|
Total
|
||||||
Net income attributable to the Partnership:
|
|
|
|
|
|
|
||||||
Distribution declared
|
|
$
|
39,559
|
|
|
$
|
733
|
|
|
$
|
40,292
|
|
Distribution in excess of net income
|
|
(2,828
|
)
|
|
—
|
|
|
(2,828
|
)
|
|||
Net income
|
|
$
|
36,731
|
|
|
$
|
733
|
|
|
$
|
37,464
|
|
Weighted average units outstanding:
|
|
|
|
|
|
|
||||||
Basic and diluted
|
|
32,238,663
|
|
|
|
|
32,238,663
|
|
||||
Net income per limited partner unit:
|
|
|
|
|
|
|
||||||
Basic and diluted
|
|
$
|
1.14
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2017
|
||||||||||||||
|
|
Limited Partners' Common Units
|
|
Limited Partners' Subordinated Units
|
|
Incentive Distribution Rights
|
|
Total
|
||||||||
Net income attributable to the Partnership:
|
|
|
|
|
|
|
|
|
||||||||
Distribution declared
|
|
$
|
22,454
|
|
|
$
|
9,133
|
|
|
$
|
1,052
|
|
|
$
|
32,639
|
|
Net income in excess of distribution (distribution in
excess of net income)
|
|
624
|
|
|
(139
|
)
|
|
—
|
|
|
485
|
|
||||
Net income
|
|
$
|
23,078
|
|
|
$
|
8,994
|
|
|
$
|
1,052
|
|
|
$
|
33,124
|
|
Weighted average units outstanding:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
18,686,701
|
|
|
8,410,941
|
|
|
|
|
27,097,642
|
|
|||||
Net income per limited partner unit:
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted
|
|
$
|
1.23
|
|
|
$
|
1.07
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Distributions per common unit
|
|
$
|
0.4088
|
|
|
$
|
0.3650
|
|
|
$
|
1.1927
|
|
|
$
|
1.0649
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Net sales—Westlake
|
|
$
|
313,381
|
|
|
$
|
258,049
|
|
|
$
|
802,085
|
|
|
$
|
711,968
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Feedstock purchased from Westlake and included in cost
of sales
|
|
$
|
178,493
|
|
|
$
|
110,241
|
|
|
$
|
403,833
|
|
|
$
|
313,231
|
|
Other charges from Westlake and included in cost of
sales
|
|
28,693
|
|
|
23,954
|
|
|
83,636
|
|
|
74,896
|
|
||||
Total
|
|
$
|
207,186
|
|
|
$
|
134,195
|
|
|
$
|
487,469
|
|
|
$
|
388,127
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Services received from Westlake and included in selling,
general and administrative expenses
|
|
$
|
4,655
|
|
|
$
|
6,633
|
|
|
$
|
17,947
|
|
|
$
|
20,311
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
Goods and services purchased from Westlake and
capitalized as assets
|
|
$
|
846
|
|
|
$
|
619
|
|
|
$
|
1,988
|
|
|
$
|
3,131
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
Receivable under the Investment Management Agreement
|
|
$
|
151,875
|
|
|
$
|
136,510
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
Accounts receivable—Westlake
|
|
$
|
65,628
|
|
|
$
|
43,884
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
Accounts payable—Westlake
|
|
$
|
41,274
|
|
|
$
|
14,027
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
Long-term debt payable to Westlake
|
|
$
|
477,608
|
|
|
$
|
473,960
|
|
|
|
September 30,
2018 |
|
December 31,
2017 |
||||
OpCo Revolver (variable interest rate of LIBOR plus 2.0%, original scheduled maturity of
September 25, 2023)
|
|
$
|
224,064
|
|
|
$
|
220,416
|
|
MLP Revolver (variable interest rate of LIBOR plus 2.0%, original scheduled maturity of
April 29, 2021)
|
|
253,544
|
|
|
253,544
|
|
||
|
|
$
|
477,608
|
|
|
$
|
473,960
|
|
|
|
September 30, 2018
|
|
December 31, 2017
|
||||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
OpCo Revolver
|
|
$
|
224,064
|
|
|
$
|
229,622
|
|
|
$
|
220,416
|
|
|
$
|
228,180
|
|
MLP Revolver
|
|
253,544
|
|
|
255,008
|
|
|
253,544
|
|
|
258,234
|
|
•
|
our operating performance as compared to other publicly traded partnerships;
|
•
|
our ability to incur and service debt and fund capital expenditures;
|
•
|
the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities.
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
(dollars in thousands)
|
||||||||||||||
Revenue
|
|
|
|
|
|
|
|
|
||||||||
Net sales—Westlake
|
|
$
|
313,381
|
|
|
$
|
258,049
|
|
|
$
|
802,085
|
|
|
$
|
711,968
|
|
Net co-product, ethylene and other sales—third
parties
|
|
50,269
|
|
|
38,726
|
|
|
147,812
|
|
|
152,368
|
|
||||
Total net sales
|
|
363,650
|
|
|
296,775
|
|
|
949,897
|
|
|
864,336
|
|
||||
Cost of sales
|
|
269,743
|
|
|
201,372
|
|
|
666,367
|
|
|
571,401
|
|
||||
Gross profit
|
|
93,907
|
|
|
95,403
|
|
|
283,530
|
|
|
292,935
|
|
||||
Selling, general and administrative expenses
|
|
5,909
|
|
|
6,805
|
|
|
20,417
|
|
|
21,519
|
|
||||
Income from operations
|
|
87,998
|
|
|
88,598
|
|
|
263,113
|
|
|
271,416
|
|
||||
Other income (expense)
|
|
|
|
|
|
|
|
|
||||||||
Interest expense—Westlake
|
|
(5,639
|
)
|
|
(6,190
|
)
|
|
(16,052
|
)
|
|
(17,592
|
)
|
||||
Other income, net
|
|
668
|
|
|
162
|
|
|
1,742
|
|
|
1,844
|
|
||||
Income before income taxes
|
|
83,027
|
|
|
82,570
|
|
|
248,803
|
|
|
255,668
|
|
||||
Income tax provision (benefit)
|
|
(772
|
)
|
|
325
|
|
|
(186
|
)
|
|
925
|
|
||||
Net income
|
|
83,799
|
|
|
82,245
|
|
|
248,989
|
|
|
254,743
|
|
||||
Less: Net income attributable to noncontrolling
interest in OpCo
|
|
71,387
|
|
|
68,860
|
|
|
211,525
|
|
|
221,619
|
|
||||
Net income attributable to Westlake Chemical
Partners LP
|
|
$
|
12,412
|
|
|
$
|
13,385
|
|
|
$
|
37,464
|
|
|
$
|
33,124
|
|
MLP distributable cash flow
(1)
|
|
$
|
15,024
|
|
|
$
|
15,478
|
|
|
$
|
45,500
|
|
|
$
|
37,892
|
|
EBITDA
(2)
|
|
$
|
115,558
|
|
|
$
|
117,813
|
|
|
$
|
347,031
|
|
|
$
|
359,762
|
|
____________
|
|
|
|
|
|
|
|
|
||||||||
|
||||||||||||||||
(1) See "Reconciliation of MLP Distributable Cash Flow to Net Income and Net Cash Provided by Operating Activities" below.
|
||||||||||||||||
(2) See "Reconciliation of EBITDA to Net Income and Net Cash Provided by Operating Activities" below.
|
|
|
Three Months Ended September 30, 2018
|
|
Nine Months Ended September 30, 2018
|
||||||||
|
|
Average
Sales Price |
|
Volume
|
|
Average
Sales Price
|
|
Volume
|
||||
Product sales prices and volume percentage change from
prior-year period
|
|
+17.7
|
%
|
|
+4.9
|
%
|
|
+5.1
|
%
|
|
+4.8
|
%
|
|
|
|
|
|
|
|
|
|
||||
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||
Average industry prices
(1)
|
|
|
|
|
|
|
|
|
||||
Ethane (cents/lb)
|
|
14.3
|
|
|
8.8
|
|
|
10.8
|
|
|
8.3
|
|
Propane (cents/lb)
|
|
23.5
|
|
|
18.2
|
|
|
21.5
|
|
|
16.6
|
|
Ethylene (cents/lb)
(2)
|
|
17.3
|
|
|
24.7
|
|
|
18.6
|
|
|
27.8
|
|
(1)
|
Industry pricing data was obtained through IHS Markit ("IHS"). We have not independently verified the data.
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS.
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
(dollars in thousands)
|
||||||||||||||
Net cash provided by operating activities
|
|
$
|
109,433
|
|
|
$
|
139,630
|
|
|
$
|
330,004
|
|
|
$
|
401,916
|
|
Gain (loss) from disposition of fixed assets
|
|
(26
|
)
|
|
(2,734
|
)
|
|
(593
|
)
|
|
(2,627
|
)
|
||||
Changes in operating assets and liabilities and other
|
|
(25,608
|
)
|
|
(54,651
|
)
|
|
(80,422
|
)
|
|
(144,546
|
)
|
||||
Net Income
|
|
83,799
|
|
|
82,245
|
|
|
248,989
|
|
|
254,743
|
|
||||
Add:
|
|
|
|
|
|
|
|
|
||||||||
Depreciation, amortization and disposition of
property, plant and equipment
|
|
26,918
|
|
|
31,790
|
|
|
82,769
|
|
|
89,239
|
|
||||
Less:
|
|
|
|
|
|
|
|
|
||||||||
Contribution to turnaround reserves
|
|
(4,250
|
)
|
|
(7,778
|
)
|
|
(12,602
|
)
|
|
(22,641
|
)
|
||||
Maintenance capital expenditures
|
|
(8,380
|
)
|
|
(9,827
|
)
|
|
(22,184
|
)
|
|
(28,081
|
)
|
||||
Incentive distribution rights
|
|
—
|
|
|
(498
|
)
|
|
(733
|
)
|
|
(1,052
|
)
|
||||
Distributable cash flow attributable to
noncontrolling interest in OpCo
|
|
(83,063
|
)
|
|
(80,454
|
)
|
|
(250,739
|
)
|
|
(254,316
|
)
|
||||
MLP distributable cash flow
|
|
$
|
15,024
|
|
|
$
|
15,478
|
|
|
$
|
45,500
|
|
|
$
|
37,892
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
|
(dollars in thousands)
|
||||||||||||||
Net cash provided by operating activities
|
|
$
|
109,433
|
|
|
$
|
139,630
|
|
|
$
|
330,004
|
|
|
$
|
401,916
|
|
Gain (loss) from disposition of fixed assets
|
|
(26
|
)
|
|
(2,734
|
)
|
|
(593
|
)
|
|
(2,627
|
)
|
||||
Changes in operating assets and liabilities and other
|
|
(25,608
|
)
|
|
(54,651
|
)
|
|
(80,422
|
)
|
|
(144,546
|
)
|
||||
Net Income
|
|
83,799
|
|
|
82,245
|
|
|
248,989
|
|
|
254,743
|
|
||||
Add:
|
|
|
|
|
|
|
|
|
||||||||
Depreciation and amortization
|
|
26,892
|
|
|
29,053
|
|
|
82,176
|
|
|
86,502
|
|
||||
Interest expense
|
|
5,639
|
|
|
6,190
|
|
|
16,052
|
|
|
17,592
|
|
||||
Income tax provision (benefit)
|
|
(772
|
)
|
|
325
|
|
|
(186
|
)
|
|
925
|
|
||||
EBITDA
|
|
$
|
115,558
|
|
|
$
|
117,813
|
|
|
$
|
347,031
|
|
|
$
|
359,762
|
|
•
|
the amount of ethane that we are able to process, which could be adversely affected by, among other things, operating difficulties;
|
•
|
the volume of ethylene that we are able to sell;
|
•
|
the price at which we are able to sell ethylene;
|
•
|
industry market outlook, including prices and margins in third-party ethylene and co-products sales;
|
•
|
the parties to whom we will sell ethylene and on what basis;
|
•
|
volumes of ethylene that Westlake may purchase, in addition to the minimum commitment under the Ethylene Sales Agreement;
|
•
|
timing, funding and results of capital projects;
|
•
|
our intended minimum quarterly distributions and the manner of making such distributions;
|
•
|
our ability to meet our liquidity needs;
|
•
|
timing of and amount of capital expenditures;
|
•
|
the Partnership's At-the-Market program and the use of any net proceeds from any sales under that program;
|
•
|
potential loans from Westlake to OpCo to fund OpCo's expansion capital expenditures in the future;
|
•
|
expected mitigation of exposure to commodity price fluctuations;
|
•
|
turnaround activities and the variability of OpCo's cash flow;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other greenhouse gas emissions or to address other issues of climate change; and
|
•
|
effects of pending legal proceedings.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical industry;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and regulatory actions and political unrest in other countries, including environmental regulations;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our product;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations, including trade policies;
|
•
|
technological developments;
|
•
|
our ability to integrate acquired businesses;
|
•
|
foreign currency exchange risks;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Exhibit No.
|
|
Description
|
|
|
|
1.1
|
|
|
|
|
|
3.1
|
|
|
|
|
|
10.1†
|
|
|
|
|
|
10.2†
|
|
|
|
|
|
31.1†
|
|
|
|
|
|
31.2†
|
|
|
|
|
|
32.1#
|
|
|
|
|
|
101.INS†
|
|
XBRL Instance Document
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
†
|
Filed herewith.
|
#
|
Furnished herewith.
|
|
|
|
|
WESTLAKE CHEMICAL PARTNERS LP
|
||
|
|
|
|
|||
Date:
|
November 6, 2018
|
|
|
By:
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
|
|
Albert Chao
|
|
|
|
|
|
|
President, Chief Executive Officer and Director of
Westlake Chemical Partners GP LLC
(Principal Executive Officer)
|
|
|
|
|
|||
Date:
|
November 6, 2018
|
|
|
By:
|
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
|
|
|
|
|
M. Steven Bender
|
|
|
|
|
|
|
Senior Vice President, Chief Financial Officer and
Director of Westlake Chemical Partners GP LLC
(Principal Financial Officer)
|
|
WESTLAKE CHEMICAL OPCO LP
By: Westlake Chemical OpCo GP LLC, its general partner
as Borrower
|
|
|
By:
|
/S/ M. STEVEN BENDER
|
|
|
Name: Mark Steven Bender
|
|
|
Title: Senior Vice President, Chief Financial Officer and Treasurer
|
|
WESTLAKE POLYMERS LLC
By: Westlake Chemical Investments, Inc., its manager
as Lender
|
|
|
By:
|
/S/ JEFFREY HOLY
|
|
|
Name: Jeffrey Holy
|
|
|
Title: Vice President and Treasurer
|
|
WESTLAKE LONGVIEW CORPORATION
as Lender
|
|
|
By:
|
/S/ M. STEVEN BENDER
|
|
|
Name: Mark Steven Bender
|
|
|
Title: Executive Vice President and Chief Financial Officer
|
“(i)
|
the Annual Minimum Quantity (as defined below); and”
|
“(b)
|
The Annual Minimum Quantity for any Contract Year shall be equal to (i) the quantity of the Annual Planned Production notified to Buyer under
Section 3.1
in respect of the relevant Contract Year,
plus
or
minus
, as applicable, (ii) the following adjustments: (A) upward or downward if it determines, in its reasonable discretion, that any such adjustment is appropriate in order to account for operating conditions, (B) downward by the amount of any Curtailed Production during such Contract Year, and (C)
|
|
SELLER:
|
|
|
WESTLAKE CHEMICAL OPCO LP
By: Westlake Chemical OpCo GP LLC,
its general partner
|
|
|
By:
|
/S/ LAWRENCE E. TEEL
|
|
Name:
|
Lawrence E. Teel
|
|
Title:
|
Principal Operating Officer
|
|
|
|
|
BUYER:
|
|
|
WPT LLC
By: Westlake Chemical Investments, Inc.,
its Manager
|
|
|
By:
|
/S/ M. STEVEN BENDER
|
|
Name:
|
Mark Steven Bender
|
|
Title:
|
EVP & CFO
|
|
WESTLAKE VINYLS, INC.
|
|
|
By:
|
/S/ M. STEVEN BENDER
|
|
Name:
|
Mark Steven Bender
|
|
Title:
|
EVP & CFO
|
|
WESTLAKE PETROCHEMICALS LLC
By: Westlake Chemical Investments, Inc.,
its Manager
|
|
|
By:
|
/S/ M. STEVEN BENDER
|
|
Name:
|
Mark Steven Bender
|
|
Title:
|
EVP & CFO
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Westlake Chemical Partners LP;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
November 6, 2018
|
|
|
|
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
|
|
|
Albert Chao
|
|
|
|
|
|
|
|
President, Chief Executive Officer and Director of
Westlake Chemical Partners GP LLC
(Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Westlake Chemical Partners LP;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
November 6, 2018
|
|
|
|
|
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
|
|
|
|
|
|
M. Steven Bender
|
|
|
|
|
|
|
|
Senior Vice President, Chief Financial Officer and Director of Westlake Chemical Partners GP LLC
(Principal Financial Officer)
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
(2)
|
The information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Partnership.
|
Date:
|
November 6, 2018
|
|
|
|
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
|
|
|
Albert Chao
|
|
|
|
|
|
|
|
President, Chief Executive Officer and Director of
Westlake Chemical Partners GP LLC
(Principal Executive Officer)
|
|
|
|
|
|
|||
Date:
|
November 6, 2018
|
|
|
|
|
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
|
|
|
|
|
|
M. Steven Bender
|
|
|
|
|
|
|
|
Senior Vice President, Chief Financial Officer and
Director of Westlake Chemical Partners GP LLC
(Principal Financial Officer)
|